No Data
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Kamada Declares $0.20 Dividend
Express News | Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders
Press Release: Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders
Benchmark Co. Initiates Kamada(KMDA.US) With Buy Rating, Announces Target Price $15
Kamada Initiated at Buy by Benchmark
! As always, Thank you for this updated information. Time to dig in and do my DD!